ArticleCancer research communications2025

Chemoimmunotherapy Outcomes and Prognostic Factors in Patients with Advanced, Low PD-L1-Expressing Non-Small Cell Lung Cancer.

Tae Hata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.